Thoracic Surgery Grand Rounds
April 8, 2015
Using Induction Radiation in Addition to Chemotherapy Does Not Improve Survival of Patients Who Have Resection of Stage IIIA (N2) Non-Small Cell Lung Cancer
Chi Fu Jeffrey Yang, MD
Does Moderate Hypothermia Really Carry Less Bleeding Risk than Deep Hypothermia For Circulatory Arrest? A Propensity-Matched Comparison in Hemiarch Replacement
Jeffrey Keenan, MD
Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I-II Non-Small Cell Lung Cancer
Brian Gulack, MD
Presenter disclosure of financial relationships: Drs. Yang, Keenan, and Gulack indicate no financial relationships relative to the content presented and no personal/financial relationships to disclose which are relative to this activity.
Dr. D’Amico has no personal/financial relationships to disclose which are relative to this activity. Dr. D'Amico indicates serving as a consultant with Scanlan.
Global Learning Objectives:
1. Review and discuss technical aspects of cardiothoracic surgery.
2. Discuss clinical research findings and advances in thoracic surgery.
3. Present and discuss case studies, protocols and treatment guidelines
as appropriate to the thoracic surgery practice.
RSS Activity Medical Director(s) Disclosure: Dr. Thomas D’Amico has no personal/financial relationships to disclose which are relative to this activity. Dr. D'Amico indicates serving as a consultant with Scanlan.
The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
---Unapproved Use Disclosure---
Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (Not FDA approved) ; and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and /or unsupported opinion. Faculty at this event may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education, and is not intended to promote off-label use of these medications. If you have any questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
The Duke University School Of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in this activity.